Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease
- 1 November 2015
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 78 (10) , 702-710
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR7361/MED/30/953/2013)
This publication has 54 references indexed in Scilit:
- A Reversible Early Oxidized Redox State That Precedes Macromolecular ROS Damage in Aging Nontransgenic and 3xTg-AD Mouse NeuronsThe Journal of Neuroscience, 2012
- Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adultsJournal of the International Neuropsychological Society, 2010
- Detergent‐Insoluble EAAC1/EAAT3 Aberrantly Accumulates in Hippocampal Neurons of Alzheimer's Disease PatientsBrain Pathology, 2009
- Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS StudyPLOS ONE, 2008
- Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's diseaseNeurobiology of Aging, 2006
- Gender differences in glutathione metabolism in Alzheimer's diseaseJournal of Neuroscience Research, 2005
- Glutathione Pathways in the BrainBiological Chemistry, 2003
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984